The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes

被引:194
作者
Peschel, A [1 ]
Vuong, C [1 ]
Otto, M [1 ]
Götz, F [1 ]
机构
[1] Univ Tubingen, D-72076 Tubingen, Germany
关键词
D O I
10.1128/AAC.44.10.2845-2847.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recently, Staphylococcus aureus strains with intermediate resistance to vancomycin, the antibiotic of last resort, have been described. Multiple changes in peptidoglycan turnover and structure contribute to the resistance phenotype. Here, we describe that structural changes of teichoic acids in the cell envelope have a considerable influence on the susceptibility to vancomycin and other glycopeptides. S. aureus cells lacking D-alanine esters in teichoic acids exhibited an at least threefold-increased sensitivity to glycopeptide antibiotics, Furthermore, the autolytic activity of the D-alanine mutant was reduced compared to the wild-type, and the mutant was more susceptible to the staphylolytic enzyme lysostaphin, Vancomycin inhibited autolysis at very high concentrations but neither in the wild-type nor in the mutant was the autolytic activity influenced in the range of the MIG. Mutant cells had a considerably higher capacity to bind vancomycin.
引用
收藏
页码:2845 / 2847
页数:3
相关论文
共 22 条
[1]   Glycopeptide resistance in enterococci [J].
Arthur, M ;
Reynolds, P ;
Courvalin, P .
TRENDS IN MICROBIOLOGY, 1996, 4 (10) :401-407
[2]   Target cell specificity of a bacteriocin molecule: A C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus [J].
Baba, T ;
Schneewind, O .
EMBO JOURNAL, 1996, 15 (18) :4789-4797
[3]   PHYSIOLOGY OF LIPOTEICHOIC ACIDS IN BACTERIA [J].
FISCHER, W .
ADVANCES IN MICROBIAL PHYSIOLOGY, 1988, 29 :233-302
[4]  
FISCHER W, 1997, NEW TARGETS NEW ANTI, P47
[5]   Penicillin tolerance and modification of lipoteichoic acid associated with expression of vancomycin resistance in VanB-type Enterococcus faecium D366 [J].
Gutmann, L ;
AlObeid, S ;
BillotKlein, D ;
Ebnet, E ;
Fischer, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :257-259
[6]   Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50 [J].
Hanaki, H ;
Labischinski, H ;
Inaba, Y ;
Kondo, N ;
Murakami, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) :315-320
[7]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[8]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[9]   Teichoic acid content in different lineages of Staphylococcus aureus NCTC8325 [J].
Jenni, R ;
Berger-Bächi, B .
ARCHIVES OF MICROBIOLOGY, 1998, 170 (03) :171-178
[10]   Medical progress -: Staphylococcus aureus infections [J].
Lowy, FD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) :520-532